Western IRB, a provider of ethical research review serving 2,300 academic medical centers and hospitals, announced today an alliance with Huron, a global professional services firm serving the health care, higher education, life sciences, and commercial sectors.
The National Coalition for Cancer Survivorship launched a nationwide competition for the 2017 Ellen L. Stovall Award for Innovation in Patient-Centered Cancer Care, an opportunity for patients and survivors to recognize exceptional providers who are transforming cancer care.
Luis Diaz was named the head of the Division of Solid Tumor Oncology in the Department of Medicine at Memorial Sloan Kettering Cancer Center as David Spriggs steps down after nearly 13 years.
MD Anderson Cancer Center and Lion Biotechnologies Inc, a biotechnology company developing cancer immunotherapies based on tumor-infiltrating lymphocyte technology, announced a multi-year strategic alliance agreement involving multi-arm clinical trials to evaluate the safety and efficacy of TIL therapy in ovarian, various sarcomas, and pancreatic cancers.
The National Comprehensive Cancer Network added recommendations from an additional nine NCCN Clinical Practice Guidelines in Oncology to its NCCN Radiation Therapy Compendium:
Ronald DeMatteo was appointed chair of the Department of Surgery in the Perelman School of Medicine at the University of Pennsylvania, effective July 1.
Ahmad Samer Al-Homsi will lead a new bone marrow transplantation program at the NYU Langone Perlmutter Cancer Center for treating blood-borne cancers, and potentially utilize transplantation as an adjunct to immunotherapy for solid tumors.
Ophira Ginsburg has joined NYU Langone's Perlmutter Cancer Center as director of its new High Risk Program, which identifies, studies and cares for patients with hereditary syndromes that increase cancer risk.
Katrina Studvent accepted the position of chief development officer at the Barbara Ann Karmanos Cancer Institute. She reports directly to Karmanos President & CEO Gerold Bepler.
Michael Caligiuri became president of the American Association for Cancer Research for 2017-2018.
